Myriad Genetics | MYGN - Selling And Administration Expenses

Stock Price
4.78
Daily Change
-0.01 -0.21%
Monthly
2.14%
Yearly
-35.58%
Q2 Forecast
4.68

Myriad Genetics reported $122.3M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agilent USD 476M 48M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Bio-Rad Laboratories USD 206.8M 900K Sep/2025
Bruker USD 247.2M 4.7M Dec/2025
Danaher USD 1.86B 166M Mar/2026
Illumina USD 283M 27M Dec/2025
J&J USD 6.03B 719M Mar/2026
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Myriad Genetics USD 122.3M 6.7M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Quest Diagnostics USD 504M 0 Mar/2026
Quidel USD 194.4M 7.5M Dec/2025
Repligen USD 74.36M 703K Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
Standard Biotools USD 21.55M 5.05M Dec/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Veracyte USD 43.31M 8.43M Dec/2025
Waters USD 240.01M 25.78M Dec/2025